share_log
Moomoo 24/7 ·  Apr 24 09:04
Capricor Therapeutics: FDA Feedback Supports Requests for Pre-Bla Meeting,Subsequent Rolling Bla Submission Following Upcoming Q2 Type-B FDA Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment